Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 26, 2026
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 24, 2026
Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinib.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 06, 2026
First-Line Integration of Local Ablative Therapy With EGFR Tyrosine Kinase Inhibitors in Advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 01, 2026
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 02, 2026
MTAP loss is frequent in oncogene-driven NSCLC and may confer sensitivity to combined PRMT5 inhibitors and targeted therapies.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 02, 2026
Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 18, 2026
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 23, 2025
Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 17, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma Registry.
Journal: JCO precision oncology
Published: December 05, 2025
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 17, 2025
Updates on the Perioperative Management of Resectable Non-Small Cell Lung Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 27, 2025
Last Updated: 09/26/2026